On 20 September 2011, the OFT published its 12 April 2011 decision relating to Reckitt Benckiser’s abuse of dominance in the market for the supply of alginates and antacids by prescription in the UK. The decision found that by withdrawing and de-listing NHS presentation packs of Gaviscon Original Liquid, Reckitt Benckiser had abused its dominant position on the alginates and antacids market. Read more.